Ozempic and Aleve drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ozempic (semaglutide) and Aleve (naproxen sodium). Common drug interactions include hypophagia among females and blood pressure decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Ozempic and Aleve. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Ozempic?

Ozempic has active ingredients of semaglutide. It is often used in weight loss. eHealthMe is studying from 29,761 Ozempic users. Check the latest studies of Ozempic.

What is Aleve?

Aleve has active ingredients of naproxen sodium. It is often used in pain. eHealthMe is studying from 70,279 Aleve users. Check the latest studies of Aleve.



On Jul, 17, 2026

48 people who take Ozempic and Aleve together, and have interactions are studied.

Ozempic and Aleve drug interactions.

What are the common drug interactions of Ozempic and Aleve, by gender? *:

female:

  1. Hypophagia (reduced food intake)
  2. Incontinence (lack of moderation or self-control)
  3. Injection site pain
  4. Irritable bowel syndrome
  5. Kidney infection
  6. Localised infection (infection at the single location)
  7. Memory impairment
  8. Migraine (headache)
  9. Mobility decreased (ability to move is reduced)
  10. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

male:

  1. Blood pressure decreased
  2. Abdominal distension
  3. Chest pain
  4. Constipation
  5. Cough
  6. Diabetic ulcer
  7. Discomfort
  8. Dizziness
  9. Drug ineffective
  10. Dyspepsia (indigestion)

What are the common drug interactions of Ozempic and Aleve, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  2. Irritable bowel syndrome
  3. Migraine (headache)
  4. Ovarian cyst (fluid filled sac of the ovary)
  5. Thyroid cyst

30-39:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  3. Abscess limb (limb infection)
  4. Anal abscess
  5. Genital abscess (build up of pus in genital)
  6. Groin abscess (pus in groin)
  7. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  8. Perineal abscess
  9. Scrotal abscess (pus in scrotum)

40-49:

  1. Drug ineffective
  2. Nephrolithiasis (calculi in the kidneys)
  3. Back pain
  4. Blood cholesterol increased
  5. Impaired work ability
  6. Inflammation
  7. Fatigue (feeling of tiredness)
  8. Kidney infection
  9. Localised infection (infection at the single location)
  10. Mobility decreased (ability to move is reduced)

50-59:

  1. Abdominal discomfort
  2. Abdominal distension
  3. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  4. Chest pain
  5. Dermatitis allergic (inflammation of the skin due allergic reaction)
  6. Discomfort
  7. Drug ineffective
  8. Dyspepsia (indigestion)
  9. Dyspnoea (difficult or laboured respiration)
  10. Flatulence (flatus expelled through the anus)

60+:

  1. Pain in extremity
  2. Arthralgia (joint pain)
  3. Diarrhoea
  4. Drug ineffective
  5. Fatigue (feeling of tiredness)
  6. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  7. Injection site discolouration
  8. Knee arthroplasty
  9. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  10. Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

  1. Diabetes: 7 people, 14.58%
  2. High Blood Pressure: 6 people, 12.50%
  3. Type 2 Diabetes: 5 people, 10.42%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 10.42%
  5. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 10.42%
  6. Psoriasis (immune-mediated disease that affects the skin): 4 people, 8.33%
  7. Joint Pain: 4 people, 8.33%
  8. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 6.25%
  9. Nausea (feeling of having an urge to vomit): 3 people, 6.25%
  10. Migraine (headache): 3 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ozempic and Aleve?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ozempic and Aleve:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ozempic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aleve:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ozempic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aleve and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on semaglutide and naproxen sodium (the active ingredients of Ozempic and Aleve, respectively), and Ozempic and Aleve (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: